NCT05116553 is a NA clinical trial of SDT in Motivation, sponsored by Idego srl.

Who is sponsoring NCT05116553?

NCT05116553 is sponsored by Idego srl.

What drugs are being tested in NCT05116553?

Interventions in NCT05116553: SDT, APP + CA.

What condition does NCT05116553 study?

NCT05116553 studies Motivation, Self Efficacy.

Is NCT05116553 still recruiting?

NCT05116553 is currently completed. Last updated 21 January 2022.

Last reviewed 2022-01-21 · How we verify

NCT05116553

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

Completed NA Last updated 21 January 2022

What this trial tests

NA trial testing SDT in Motivation in 74 participants. Completed in 20 January 2022.

Timeline

11 November 2021

Primary endpoint
31 December 2021

20 January 2022

Quick facts

Lead sponsor	Idego srl
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	74
Start date	11 November 2021
Primary completion	31 December 2021
Estimated completion	20 January 2022
Sites	1 location across Italy

Drugs / interventions tested

SDT
APP + CA

Conditions studied

Motivation — all drugs for Motivation →
Self Efficacy — all drugs for Self Efficacy →

Sponsor

Idego srl

Who can join

Adults 50 to 67, any sex, with Motivation or Self Efficacy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Motivation

Currently open trials in the same condition.

NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07067554 — Breastfeeding Myths and Mothers' Motivation · recruiting
NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
NCT06826703 — The Effect of Motivational Interviewing on Diabetes Self-Management and Severity of Cyberchondria in Individuals With Di · NA · recruiting
NCT07143123 — Enhancing Nursing Skills With SimCapture Technology · NA · active not recruiting

Other Idego srl trials

Trials by the same sponsor.

NCT05966844 — Golden Age: Virtual Reality and Mindfulness · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05116553 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Idego srl
Last refreshed: 21 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05116553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing